Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study: Monitoring Levodopa-Induced Dyskinesia Using Accelerometer & Gyroscope-based Motion Detection System

NCT01429207 is registered in ClinicalTrials.gov with Great Lakes NeuroTechnologies Inc. as lead sponsor.

NCT NCT01429207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01429207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study: Monitoring Levodopa-Induced Dyskinesia Using Accelerometer & Gyroscope-based Motion Detection System
Lead sponsor
Great Lakes NeuroTechnologies Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
Not reported
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyskinesia, parkinson's disease